Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 1, 2026Reported sale · Form 4Richard A. Heyman · $45.2KOpen the filing ↗
- Oct 1, 2026Reported sale · Form 4Richard A. Heyman · $41.3KOpen the filing ↗
- Oct 1, 2026Notice of sale · Form 144Richard A, Heyman · Director · $109.1KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record39317 flagged findings
Reported transactions (Form 4)80since Jan 2, 2025
Corporate events (8-K)18since Jun 10, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
The 25 most recent filings (of 393)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 2, 26Form 4 ↗Insider transaction
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Oct 1, 26Form 144 ↗Notice of proposed sale
- Oct 1, 26Form 144 ↗Notice of proposed sale
- Aug 26, 26Form 144 ↗Notice of proposed sale
- Aug 3, 2610-Q ↗Quarterly report
- Aug 3, 268-K ↗Current report · Results
- Jul 30, 268-K ↗Current report · A senior executive left or was appointed
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Jul 6, 26Form 144 ↗Notice of proposed sale
- Jul 6, 26Form 144 ↗Notice of proposed sale
- Jun 22, 268-K ↗Current report · A senior executive left or was appointed
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Venrock Healthcare Capital Partners III, L.P. · 4.2% · event on Mar 31, 26 · amendment
- May 15, 26SCHEDULE 13G/A ↗Passive stake · amendment
- May 15, 26SCHEDULE 13G/A ↗Passive stake · VIKING GLOBAL INVESTORS LP · 7.8% · event on Mar 31, 26 · amendment
- May 15, 26SCHEDULE 13G ↗Passive stake · T. Rowe Price Associates, Inc. · 5.4% · event on Mar 31, 26
- May 12, 26SCHEDULE 13G/A ↗Passive stake · Pfizer Inc. (IRS Identification No.: 13-5315170) · 3.3% · event on Mar 31, 26 · amendment
- May 4, 2610-Q ↗Quarterly report
- May 4, 268-K ↗Current report · Results
- Apr 28, 26DEFA14A ↗Shareholder meeting and votes
- Apr 28, 26DEF 14A ↗Shareholder meeting and votes
- Mar 31, 268-K ↗Current report · Other events
393 filings on record, the oldest from Jan 9, 20.
Listing the 25 most recent filings of the 393 on record.
198
- Jul 30, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 22, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 12, 25Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- May 28, 25Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Mar 14, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 29, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 22, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jun 27, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Mar 4, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 10, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 16, 21Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 6, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
2 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- SR One Capital Management, LLC4.8%Aug 12, 25SCHEDULE 13D/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Nextech Crossover I GP S.a. r.l.8.4%Jun 30, 25SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- VIKING GLOBAL INVESTORS LP7.8%Mar 31, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- EcoR1 Capital, LLC6.9%Jul 29, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.5.6%Dec 31, 25SCHEDULE 13G ↗1 earlier filing
- T. Rowe Price Associates, Inc.5.4%Mar 31, 26SCHEDULE 13G ↗
show 5 more holdershide
- Point72 Asset Management, L.P.5.1%May 29, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Alkeon Capital Management LLC4.6%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Venrock Healthcare Capital Partners III, L.P.4.2%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- David V Goeddel3.7%Sep 30, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Pfizer Inc. (IRS Identification No.: 13-5315170)3.3%Mar 31, 26SCHEDULE 13G/A ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Oct 1, Richard A, Heyman filed notice of intent to sell up to $109K. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $87K across 2 trades on Oct 1, per their Form 4. That is 83% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+4 more recent notices · 2 with a later sale
- Oct 1, 26Sell$45KRichard A. Heyman↗
- Oct 1, 26Sell$41KRichard A. Heyman↗
- Sep 28, 26Sell$181KDominic PiscitelliChief Financial Officer↗
- Sep 24, 26Sell$1KDominic PiscitelliChief Financial Officer↗
- Sep 24, 26Sell$7KDominic PiscitelliChief Financial Officer↗
- Aug 26, 26Sell$1.1MDominic PiscitelliChief Financial Officer↗
- Jul 24, 26Sell$84KRichard A. Heyman↗
- Jul 24, 26Sell$73KRichard A. Heyman↗
- Jul 6, 26Sell$4KRichard A. Heyman↗
- Feb 24, 26Sell$703KDominic PiscitelliChief Financial Officer↗
- Jan 16, 26Sell$42KRichard A. Heyman↗
- Jan 16, 26Sell$38KRichard A. Heyman↗
There are 13 more transactions in this stretch.
Stock compensation, tax and giftsshow the 15 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Oct 1, 26Compensation$6KRichard A. Heyman↗
- Sep 28, 26Compensation$58KDominic PiscitelliChief Financial Officer↗
- Sep 24, 26Compensation$3KDominic PiscitelliChief Financial Officer↗
- Aug 26, 26Compensation$227KDominic PiscitelliChief Financial Officer↗
- Aug 26, 26Compensation$150KDominic PiscitelliChief Financial Officer↗
- Jul 24, 26Compensation$6KRichard A. Heyman↗
- Feb 24, 26Compensation$227KDominic PiscitelliChief Financial Officer↗
- Dec 15, 25Compensationamount n/aPratik S MultaniChief Medical Officer↗
- Dec 15, 25Compensationamount n/aJacob ChackoPRESIDENT AND CEO↗
- Dec 15, 25Compensationamount n/aDominic PiscitelliChief Financial Officer↗
- Dec 8, 25Compensation$79KLori Anne Kunkel↗
- Dec 4, 25Compensation$21KLori Anne Kunkel↗
- Oct 6, 25Compensation$48KDominic PiscitelliChief Financial Officer↗
- Oct 3, 25Compensation$50KRichard A. Heyman↗
- Oct 3, 25Compensation$5KRichard A. Heyman↗
The full record holds 72 transactions and goes back to Dec 15, 22.
Its sector and its market
Oric Pharmaceuticals Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Oric Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Oric Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 393 documents on file, from Jan 9, 2020 to Oct 2, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.